Launched in 1978, Biogen is a leading world wide biotechnology corporation which includes pioneered many breakthrough improvements which include a broad portfolio of medicines to treat multiple sclerosis, the 1st permitted remedy for spinal muscular atrophy, two co-developed solutions to address a defining pathology of Alzheimer’s disorder, the v